Nanolek

Nanolek is a prominent Russian biopharmaceutical company focused on the development and manufacturing of innovative medicines, particularly vaccines and orphan drugs. Established in 2011, the company operates a high-tech, GMP-certified manufacturing facility in the Kirov region, which serves as a hub for both proprietary R&D and the localization of global pharmaceutical products. Nanolek plays a critical role in the Russian National Immunization Calendar, notably as a primary supplier of the inactivated polio vaccine. Through strategic partnerships with international leaders such as Sanofi, Merck, and Green Cross, the company has built a diverse portfolio that includes treatments for rare genetic disorders, oncology, and cardiovascular conditions. Nanolek is a key driver of import substitution in the Russian healthcare sector, aiming to provide affordable access to advanced therapeutic solutions.